VCI Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235K Sell
962
-14,863
-94% -$3.46M 0.07% 119
2025
Q4
$3.27M Sell
15,825
-359
-2% -$71K 0.91% 24
2025
Q3
$3M Buy
16,184
+261
+2% +$44.7K 0.91% 25
2025
Q2
$2.43M Buy
15,923
+1,864
+13% +$287K 0.85% 28
2025
Q1
$2.33M Sell
14,059
-5,340
-28% -$836K 0.98% 23
2024
Q4
$2.81M Buy
19,399
+4,805
+33% +$745K 1.19% 21
2024
Q3
$2.37M Buy
+14,594
New +$2.33M 1.05% 24
2024
Q1
Sell
-1,768
Closed -$277K 116
2023
Q4
$277K Buy
+1,768
New +$271K 0.17% 93

Other funds holding JNJ

VCI Wealth Management's JNJ Position: Q1 2026 in Review

VCI Wealth Management reduced its Johnson & Johnson (JNJ) stake by 94% in Q1 2026, selling an estimated $3.46M and leaving 962 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #119.

VCI Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 8 quarters since. The position peaked at $3.27M in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • VCI Wealth Management held 962 shares of Johnson & Johnson worth $235K as of Q1 2026.
  • VCI Wealth Management sold 14,863 Johnson & Johnson shares in Q1 2026, an estimated $3.46M.
  • Johnson & Johnson made up 0.07% of VCI Wealth Management's portfolio in Q1 2026, its #119 holding.
  • VCI Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 8 quarters since.
  • VCI Wealth Management's Johnson & Johnson position peaked at $3.27M in Q4 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on VCI Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.